Explore how rim enhancement on imaging serves as a biomarker for aggressive pancreatic ductal adenocarcinoma, with insights from systematic review and meta-analysis.
Exploring how omics sciences are revolutionizing our understanding and treatment of pancreatic cancer through genomics, metabolomics, and innovative therapies.